Burning Rock Biotech (BNR) Assets: 2020-2025
Historic Assets for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $114.1 million.
- Burning Rock Biotech's Assets fell 18.70% to $114.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $468.3 million, marking a year-over-year decrease of 16.97%. This contributed to the annual value of $121.3 million for FY2024, which is 17.20% down from last year.
- Burning Rock Biotech's Assets amounted to $114.1 million in Q3 2025, which was down 0.93% from $115.2 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Assets peaked at $409.4 million during Q1 2021, and registered a low of $114.1 million during Q3 2025.
- Its 3-year average for Assets is $143.8 million, with a median of $140.3 million in 2024.
- Its Assets has fluctuated over the past 5 years, first crashed by 37.93% in 2023, then grew by 12.24% in 2024.
- MRQ analysis of 5 years shows Burning Rock Biotech's Assets stood at $357.6 million in 2021, then tumbled by 35.63% to $230.2 million in 2022, then plummeted by 36.36% to $146.5 million in 2023, then dropped by 17.20% to $121.3 million in 2024, then dropped by 5.94% to $114.1 million in 2025.
- Its Assets was $114.1 million in Q3 2025, compared to $115.2 million in Q2 2025 and $117.8 million in Q1 2025.